Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
China flag China · Delayed Price · Currency is CNY
3.270
-0.020 (-0.61%)
At close: Feb 13, 2026

SHE:002589 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
4,8544,4444,9206,1655,8817,826
Market Cap Growth
16.25%-9.67%-20.19%4.83%-24.86%-31.99%
Enterprise Value
6,5497,0223,5017,78511,38210,805
Last Close Price
3.272.973.244.083.895.15
PE Ratio
-215.52242.17-44.8329.95
Forward PE
-8.028.028.028.4512.23
PS Ratio
0.660.560.610.500.280.29
PB Ratio
0.890.780.871.070.610.74
P/TBV Ratio
1.040.901.041.330.911.23
P/FCF Ratio
175.7990.86-17.51--
P/OCF Ratio
25.6527.7059.6711.7913.2818.86
PEG Ratio
-0.360.360.360.360.36
EV/Sales Ratio
0.900.880.440.630.540.40
EV/EBITDA Ratio
55.4236.5126.7546.9110.226.31
EV/EBIT Ratio
-228.27--13.997.60
EV/FCF Ratio
237.19143.54-22.11--
Debt / Equity Ratio
1.071.161.210.700.470.96
Debt / EBITDA Ratio
49.3433.6550.4022.864.015.87
Debt / FCF Ratio
211.20134.50-11.37--
Net Debt / Equity Ratio
0.290.280.31-0.230.000.41
Net Debt / EBITDA Ratio
13.838.2913.47-8.05-0.032.49
Net Debt / FCF Ratio
57.6032.61-8.17-3.791.92-18.96
Asset Turnover
0.460.490.460.550.720.84
Inventory Turnover
8.347.666.967.076.926.80
Quick Ratio
1.021.030.960.931.081.06
Current Ratio
1.111.121.071.031.251.25
Return on Equity (ROE)
0.42%0.72%0.56%-22.52%3.78%6.02%
Return on Assets (ROA)
-0.03%0.12%-0.30%-0.30%1.74%2.75%
Return on Invested Capital (ROIC)
-0.09%0.41%-1.43%-1.54%5.47%7.32%
Return on Capital Employed (ROCE)
-0.10%0.50%-1.40%-1.90%8.20%13.00%
Earnings Yield
-0.00%0.46%0.41%-29.70%2.23%3.34%
FCF Yield
0.57%1.10%-4.39%5.71%-0.31%-2.88%
Dividend Yield
0.24%0.37%0.40%-0.23%0.35%
Payout Ratio
-963.58%992.70%-241.13%132.63%
Buyback Yield / Dilution
0.64%-0.01%-1.93%-1.30%-0.40%2.99%
Total Shareholder Return
0.89%0.36%-1.53%-1.30%-0.17%3.34%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.